Sonja Kopanja

Sonja Kopanja

Auto-generated profile, based on publicly available information

Sonja Kopanja

Division of Paediatric Pulmonology, Allergy and Endocrinology, Department of Paediatrics and Adolescent Medicine, Comprehensive Centre of Paediatrics Medical University of Vienna Vienna Austria

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2024 in Allergy
Verified
Journal Article
Open access
PDF file
VDVarsha Dwivedi
Varsha Dwivedi
SKSonja Kopanja
Sonja Kopanja
KSKlara Schmidthaler
Klara Schmidthaler
JSJustyna Sieber
Justyna Sieber
CBChristina Bannert
Christina Bannert
ZSZsolt Szepfalusi
Zsolt Szepfalusi
The efficacy and safety of preventive allergen immunotherapy (pAIT) in children are currently under investigation. Here, we provide an overview of pAIT with respiratory allergens concerning the prevention of new sensitizations, allergic disease onset and progression as well as further immunomodulatory effects. Three databases were searched for clinical pAIT studies in children. Selected publications were reviewed for preventive outcomes according to prevention level (primary, secondary, and tertiary), allergen type, administration route, dose, and treatment duration. The primary prevention approach appears safe but showed no allergen‐specific effect on new sensitizations. Secondary prevention seems feasible and may induce regulatory T cell‐mediated immunotolerance. The number of studies at these prevention levels is limited. Tertiary prevention with grass and/or tree pollen‐based pAIT has shown efficacy in preventing disease progression from allergic rhinitis/conjunctivitis to asthma. Data on tertiary pAIT with house dust mites and other allergen types are inconclusive. Subcutaneous and sublingual routes appear similarly effective, but head‐to‐head comparative paediatric studies are scarce. Additionally, there are fewer placebo‐controlled studies. Nevertheless, immunomodulatory outcomes of pAIT are encouraging. Currently, limited but favourably suggestive evidence is available for preventing respiratory allergic diseases in children by pAIT. Primary and secondary prevention have potential and warrant further investigation through well‐designed studies.

21 February 2022 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
PDF file
SKSonja Kopanja
Sonja Kopanja
PGPia Gattinger
Pia Gattinger
KSKlara Schmidthaler
Klara Schmidthaler
JSJustyna Sieber
Justyna Sieber
KNKatarzyna Niepodziana
Katarzyna Niepodziana
ZSZsolt Szepfalusi
Zsolt Szepfalusi
Background: While children usually experience a mild course of COVID‐19, and a severe disease is more common in adults, the features, specificities, and functionality of the SARS‐CoV‐2‐specific antibody response in the pediatric population are of interest.Methods: We performed a detailed analysis of IgG antibodies specific for SARS‐CoV‐2‐derived antigens S and RBD by ELISA in 26 SARS‐CoV‐2 seropositive schoolchildren with mild or asymptomatic disease course, and in an equally sized, age‐ and gender‐matched control group. Furthermore, a detailed mapping of IgG reactivity to a panel of microarrayed SARS‐CoV‐2 proteins and S‐derived peptides was performed by microarray technology. The capacity of the antibody response to block RBD‐ACE2 binding and virus neutralization were assessed. Results were compared with those obtained in an adult COVID‐19 convalescent population.Results: After mild COVID‐19, anti‐S and RBD‐specific IgG antibodies were developed by 100% and 84.6% of pediatric subjects, respectively. No difference was observed in regards to symptoms and gender. Mounted antibodies recognized conformational epitopes of the spike protein and were capable to neutralize the virus up to a titer of ≥80 and to inhibit the ACE2‐RBD interaction by up to 65%. SARS‐CoV‐2‐specific IgG responses in children were comparable to mildly affected adult patients.Conclusion: SARS‐CoV‐2 asymptomatic and mildly affected pediatric patients develop a SARS‐CoV‐2‐specific antibody response, which is comparable regarding antigen, epitope recognition, and the ability to inhibit the RBD‐ACE2 interaction to that observed in adult patients after mild COVID‐19.

27 January 2023 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
JSJustyna Sieber
Justyna Sieber
KSKlara Schmidthaler
Klara Schmidthaler
SKSonja Kopanja
Sonja Kopanja
LWLukas Weseslindtner
Lukas Weseslindtner
KSKarin Stiasny
Karin Stiasny
ZSZsolt Szepfalusi
Zsolt Szepfalusi
Background: The impact of children on the transmission of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) remains uncertain. This study provides an insight into distinct patterns of SARS‐CoV‐2 household transmission in case of pediatric and adult index cases as well as age‐dependent susceptibility to SARS‐CoV‐2 infection.Methods: Immune analysis, medical interviewing, and contact tracing of 26 families with confirmed SARS‐CoV‐2 infection cases have been conducted. Blood samples were analyzed serologically with the use of a SARS‐CoV‐2‐specific IgG assay and virus neutralization test (VNT). Uni‐ and multivariable linear regression and mixed effect logistic regression models were used to describe potential risk factors for higher contagiousness and susceptibility to SARS‐CoV‐2 infection.Results: SARS‐CoV‐2 infection could be confirmed in 67 of 124 family members. Fourteen children and 11 adults could be defined as index cases in their households. Forty of 82 exposed family members were defined as secondarily infected. The mean secondary attack rate in households was 0.48 and was significantly higher in households with adult than with pediatric index cases (0.85 vs 0.19; p < 0.0001). The age (grouped into child and adult) of index case, severity of disease, and occurrence of lower respiratory symptoms in index cases were significantly associated with secondary transmission rates in households. Children seem to be equally susceptible to acquire a SARS‐CoV‐2 infection as adults, but they suffer milder courses of the disease or remain asymptomatic.Conclusion: SARS‐CoV‐2 transmission from infected children to other household members occurred rarely in the first wave of the pandemic, despite close physical contact and the lack of hygienic measures.